HPV-Associated Penile Cancer Rates by State
|Light blue||0.50 to 0.70||Colorado, Hawaii, Idaho, Kansas, Maryland, Missouri, Nevada, New Jersey, Oklahoma, Oregon, Pennsylvania, South Carolina, Utah, Washington, and Wisconsin|
|Medium blue||0.71 to 0.85||Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Nebraska, New Hampshire, North Carolina, Ohio, South Dakota, Tennessee, and West Virginia|
|Dark blue||0.87 to 1.15||Alabama, Iowa, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Mississippi, Montana, New Mexico, New York, Rhode Island, Texas, and Vermont|
|Light gray||Data not shown‡||Alaska, Arkansas, Delaware, District of Columbia, Minnesota, North Dakota, Virginia, and Wyoming|
Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard Population (19 age groups — Census P25-1130) standard.
Data are from population-based cancer registries participating in CDC’s National Program of Cancer Registries or the National Cancer Institute’s Surveillance, Epidemiology and End Results Program, include all states meeting United States Cancer Statistics publication criteria for all years 2006–2010, and cover about 94.8% of the U.S. population.
‡Rates are suppressed if the state did not meet USCS publication criteria or if there were fewer than 16 cases.
Only squamous cell carcinomas are included for penile cancer. All histological types were confirmed microscopically; definitions are specified in Watson, 2008.